En esta página
01RARE precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
RARE Ultragenyx Pharmaceutical Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 5, 2026
$15,22
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$12,73mínimo 52 semanas
$39,89máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.50B
P/E (TTM)
-2.6
BPA (TTM)
$-5.83
Ingresos (TTM)
$717M
tus insignias
Rango 52S
$13–$40
Calificación del Analista
BUY
Precio Objetivo
$28
P/E
-2.6
ROE
838.8%
Margen de Beneficio Neto
-81.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
RARE Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$15.22
Capitalización Bursátil (MRQ)
$1.50B
P/E (TTM)
-2.6
BPA (TTM)
$-5.83
Ingresos (TTM)
$717M
ROE (TTM)
838.8%
Rango 52S
$13–$40
RARE Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$673M2016-12-31 → 2025-12-31
BPA$-5.832020-12-31 → 2025-12-31
Flujo de caja libre$-472M2016-12-31 → 2025-12-31
Margen neto-81.7%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | RARE | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -2.6promedio 5A ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 2.1promedio 5A ≈9.0 | ≈9.0 | 11.4 | Infravalorado | |
| P/C (MRQ) | -5.2promedio 5A ≈3.5 | ≈3.5 | · | · | |
| Precio / FCF (TTM) | -3.1promedio 5A ≈-8.4 | ≈-8.4 | · | · | |
| Precio / Flujo de Caja (TTM) | -3.1promedio 5A ≈-9.6 | ≈-9.6 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -3.2promedio 5A ≈52.2 | ≈52.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | RARE | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -73.6%promedio 5A ≈-118.7% | ≈-118.7% | -135.5% | De primer nivel | |
| Margen EBITDA (TTM) | -69.0%promedio 5A ≈-113.4% | ≈-113.4% | -135.0% | De primer nivel | |
| Margen antes de impuestos (TTM) | -81.2%promedio 5A ≈-129.7% | ≈-129.7% | -206.8% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -81.7%promedio 5A ≈-130.1% | ≈-130.1% | -206.9% | De primer nivel | |
| ROA (TTM) | -45.6%promedio 5A ≈-37.9% | ≈-37.9% | -37.9% | En línea | |
| ROE (TTM) | 838.8%promedio 5A ≈-483.7% | ≈-483.7% | -44.0% | Débil | |
| ROIC | 673.4%promedio 5A ≈6.0% | ≈6.0% | -25.6% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | RARE | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.7promedio 5A ≈3.1 | ≈3.1 | 7.2 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.5promedio 5A ≈1.2 | ≈1.2 | 5.1 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | RARE | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 20.2%promedio 5A ≈20.3% | ≈20.3% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 22.8%promedio 5A ≈18.9% | ≈18.9% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 20.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | RARE | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.4promedio 5A ≈0.3 | ≈0.3 | 0.3 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 4.8promedio 5A ≈8.5 | ≈8.5 | 4.8 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$490.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.9%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $-0.90 | $-1.24 | 27.4% |
| 31 de marzo de 2026 | $-1.84 | $-1.54 | -19.5% | |
| 31 de diciembre de 2025 | $-1.29 | $-1.11 | -15.8% | |
| 30 de septiembre de 2025 | $-1.81 | $-1.26 | -43.7% | |
| 30 de junio de 2025 | $-1.17 | $-1.32 | 11.7% | |
| 31 de marzo de 2025 | $-1.57 | $-1.65 | 4.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Cost of Revenue | · | · | · | · | · | · | · | $1M | $1.0K | · | |
| R&D Expense | $750M | $698M | $648M | $706M | $497M | $412M | $357M | $294M | $232M | $183M | |
| SG&A Expense | $349M | $321M | $310M | $278M | $220M | $183M | $162M | $128M | $100M | $65M | |
| Operating Expenses | · | · | · | · | · | $601M | $528M | $423M | $332M | $248M | |
| Operating Income | $-535M | $-536M | $-569M | $-649M | $-382M | $-330M | $-424M | $-371M | $-329M | $-248M | |
| Interest Income | $25M | $37M | $27M | $11M | $2M | $7M | $13M | $10M | $4M | $4M | |
| Other Non-op | $1M | $-5M | $-1M | $-2M | $-2M | $607.0K | $-787.0K | $-6M | $7M | $-2M | |
| Pretax Income | $-571M | $-567M | $-609M | $-702M | $-453M | $-185M | $-399M | $-197M | $-318M | $-246M | |
| Income Tax | $4M | $2M | $-2M | $6M | $1M | $1M | $3M | $514.0K | $-16M | $35.0K | |
| Net Income | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| EPS (Basic) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| EPS (Diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| Shares (Basic) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| Shares (Diluted) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| EBITDA | $-500M | $-500M | $-543M | $-631M | $-368M | $-318M | $-416M | $-352M | $-323M | $-245M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $421M | $174M | $214M | $133M | $308M | $714M | $434M | $113M | $100M | $161M | |
| Short-term Investments | · | · | · | · | · | · | $322M | $346M | $134M | $219M | |
| Receivables | $158M | $122M | $73M | $40M | $28M | $23M | $33M | $13M | $5M | · | |
| Inventory | $52M | $45M | $34M | $27M | $16M | $13M | $12M | $7M | $757.0K | · | |
| Prepaid Expense | $61M | $40M | $48M | $69M | $72M | $58M | $51M | $43M | $29M | $20M | |
| Other Current Assets | · | · | $48M | $69M | · | · | · | · | · | · | |
| Current Assets | $951M | $817M | $732M | $884M | $857M | $1.30B | $851M | $522M | $270M | $402M | |
| PP&E (Net) | $244M | $266M | $291M | $260M | $141M | $74M | $44M | $20M | $22M | $17M | |
| PP&E (Gross) | $380M | $378M | $374M | $323M | $191M | $111M | $70M | $38M | $33M | $23M | |
| Accum. Depreciation | $136M | $112M | $83M | $63M | $50M | $37M | $26M | $18M | $11M | $6M | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | |
| Intangibles | $176M | $178M | $166M | $160M | $131M | $131M | $129M | $129M | $142M | · | |
| Other Non-current Assets | $60M | $63M | $58M | $48M | $21M | $9M | $3M | $4M | $3M | $2M | |
| Total Assets | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Accounts Payable | $31M | $39M | $42M | $43M | $17M | $13M | $13M | $12M | $9M | $5M | |
| Accrued Liabilities | $265M | $241M | $196M | $205M | $146M | $108M | $83M | $62M | $62M | $55M | |
| Current Liabilities | $384M | $344M | $280M | $261M | $181M | $190M | $103M | $75M | $71M | $60M | |
| Capital Leases | $24M | $30M | $31M | $20M | $30M | $39M | $30M | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $32M | $33M | $33M | $33M | $31M | $31M | · | |
| Other Non-current Liabilities | $44M | $17M | $12M | $5M | $1M | $7M | · | $5M | $5M | $6M | |
| Total Liabilities | $1.60B | $1.24B | $1.22B | $1.19B | $600M | $605M | $482M | $111M | $107M | $67M | |
| Common Stock | $0 | $0 | $82.0K | $70.0K | $69.0K | $67.0K | $58.0K | $51.0K | $44.0K | $41.0K | |
| Paid-in Capital | $4.45B | $4.21B | $3.66B | $3.14B | $3.00B | $2.77B | $2.09B | $1.64B | $1.22B | $1.00B | |
| Retained Earnings | $-4.53B | $-3.96B | $-3.39B | $-2.78B | $-2.07B | $-1.62B | $-1.43B | $-1.03B | $-833M | $-531M | |
| Treasury Stock | $8M | $4M | $432.0K | $0 | · | · | · | · | · | · | |
| AOCI | $1M | $-1M | $647.0K | $-7M | $-1M | $689.0K | $-147.0K | $-633.0K | $-6M | $905.0K | |
| Stockholders' Equity | $-80M | $255M | $275M | $352M | $923M | $1.15B | $654M | $609M | $383M | $474M | |
| Liabilities + Equity | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Shares Outstanding | 96,600,000 | 92,500,000 | 82,300,000 | 70,200,000 | 69,344,998 | 66,818,520 | 57,838,220 | 50,860,588 | 44,167,071 | 41,240,230 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $35M | $36M | $26M | $18M | $13M | $12M | $9M | $20M | $6M | $3M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $68M | $48M | |
| Deferred Tax | · | $-1M | $-2M | $2M | · | · | $2M | · | $-16M | · | |
| Other Non-cash | $74M | $118M | $104M | $310M | $102M | $42M | $47M | $-112M | $-9M | $33M | |
| Operating Cash Flow | $-466M | $-414M | $-475M | $-380M | $-339M | $-132M | $-345M | $-291M | $-254M | $-161M | |
| CapEx | $6M | $7M | $44M | $116M | $73M | $44M | $25M | $4M | $3M | $10M | |
| Investing Cash Flow | $236M | $-18M | $168M | $-292M | $-195M | $-179M | $-13M | $-33M | $55M | $91M | |
| Stock Issued | · | · | · | $0 | $0 | $436M | $330M | $271M | · | · | |
| Net Stock Activity | · | · | · | $0 | · | $436M | $330M | $271M | · | · | |
| Financing Cash Flow | $478M | $399M | $388M | $501M | $119M | $600M | $679M | $337M | $136M | $139M | |
| Net Change in Cash | $252M | $-35M | $81M | $-172M | $-417M | $290M | $321M | $12M | $-62M | $69M | |
| Taxes Paid | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-472M | $-422M | $-519M | $-497M | $-412M | $-176M | $-370M | $-295M | $-257M | $-171M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% | |
| Net Margin | -85.4% | -101.6% | -139.7% | -194.7% | -129.2% | -68.8% | -388.3% | -383.8% | -11567.3% | -184867.7% | |
| Pretax Margin | -84.8% | -101.3% | -140.1% | -193.1% | -128.9% | -68.4% | -385.1% | -382.8% | -12187.5% | -184841.4% | |
| EBITDA Margin | -74.3% | -89.3% | -125.1% | -173.6% | -104.9% | -117.3% | -400.8% | -683.2% | -12370.5% | -183897.0% | |
| ROA | -37.9% | -38.0% | -40.0% | -46.1% | -27.7% | -12.9% | -43.4% | -32.6% | -58.6% | -44.7% | |
| ROE | -1613.2% | -189.1% | -395.0% | -172.3% | -48.9% | -20.5% | -58.3% | -31.1% | -70.5% | -48.9% | |
| ROIC | 673.4% | -210.5% | -206.1% | -185.6% | -41.5% | -28.8% | -65.4% | -61.2% | -81.4% | -52.3% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 | 6.8 | 8.2 | 7.0 | 3.8 | 6.7 | |
| Quick Ratio | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 | 3.9 | 7.6 | 6.3 | 3.4 | 6.3 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.3 | 0.0 | · | |
| Receivables Turnover | 4.8 | 5.7 | 7.6 | 10.6 | 13.6 | 9.7 | 4.6 | 5.7 | 1.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.83 | $2.76 | $3.35 | $5.02 | $13.30 | $17.28 | $11.30 | $11.97 | $8.68 | $11.49 | |
| Revenue / Share | $6.83 | $6.19 | $5.90 | $5.20 | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.73 | $-4.57 | $-6.46 | $-5.44 | · | · | · | · | · | · | |
| Cash / Share | $4.36 | $1.88 | $2.59 | $1.89 | $4.44 | $10.68 | $7.50 | $2.23 | $2.28 | $3.91 | |
| EPS (TTM) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | $-7.01 | $-3.91 | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.2% | 29.0% | 19.4% | 3.4% | 29.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 22.8% | 16.8% | 17.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.0% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Net Income TTM | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| Market Cap | $2.22B | $3.89B | $3.94B | $3.25B | $5.83B | $9.25B | $2.47B | $2.21B | $2.05B | $2.90B | |
| P/E | -3.9 | -6.7 | -5.8 | -4.6 | -12.6 | -45.1 | -6.1 | -11.1 | · | · | |
| P/S | 3.3 | 6.9 | 9.1 | 9.0 | 16.6 | 34.1 | 23.8 | 42.9 | 784.3 | 21801.5 | |
| P/B | -27.8 | 15.2 | 14.3 | 9.2 | 6.3 | 8.0 | 3.8 | 3.6 | 5.3 | 6.1 | |
| P / Tangible Book | · | 117.9 | 61.2 | 22.1 | 7.8 | 9.4 | · | · | · | · | |
| P / Cash Flow | -4.8 | -9.4 | -8.3 | -8.5 | -17.2 | -70.0 | -7.2 | -7.6 | -8.1 | -18.0 | |
| P / FCF | -4.7 | -9.2 | -7.6 | -6.5 | -14.2 | -52.5 | -6.7 | -7.5 | -8.0 | -16.9 | |
| Earnings Yield | -25.4% | -14.9% | -17.2% | -21.8% | -8.0% | -2.2% | -16.4% | -9.0% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214M | $136M | $207M | $160M | $167M | $139M | $165M | $139M | $147M | $109M | $127M | $98M | $108M | $100M | $103M | $91M | |
| R&D Expense | $167M | $187M | $203M | $216M | $165M | $166M | $188M | $170M | $162M | $178M | $160M | $157M | $165M | $166M | $171M | $237M | |
| SG&A Expense | $88M | $88M | $88M | $87M | $87M | $87M | $82M | $80M | $81M | $78M | $77M | $75M | $81M | $77M | $73M | $70M | |
| Operating Income | $-75M | $-169M | $-113M | $-171M | $-108M | $-143M | $-122M | $-132M | $-116M | $-165M | $-122M | $-145M | $-148M | $-154M | $-146M | $-225M | |
| Interest Income | $5M | $6M | $7M | $6M | $6M | $7M | $10M | $11M | $7M | $9M | $9M | $6M | $6M | $6M | $6M | $3M | |
| Other Non-op | $1M | · | $-934.0K | $-1M | $2M | $837.0K | $-5M | $3M | $-2M | $-2M | $1M | $-699.0K | $-2M | $308.0K | $180.0K | $-1M | |
| Pretax Income | $-91M | $-184M | $-128M | $-180M | $-114M | $-150M | $-133M | $-133M | $-131M | $-170M | $-127M | $-159M | $-159M | $-163M | $-153M | $-239M | |
| Income Tax | $1M | $1M | $870.0K | $873.0K | $1M | $1M | $384.0K | $303.0K | $858.0K | $455.0K | $-4M | $650.0K | $732.0K | $495.0K | $-1M | $6M | |
| Net Income | $-92M | $-185M | $-129M | $-180M | $-115M | $-151M | $-133M | $-134M | $-132M | $-171M | $-124M | $-160M | $-160M | $-164M | $-152M | $-245M | |
| EPS (Basic) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| Shares (Basic) | 101,900,000 | 100,600,000 | · | 99,771,297 | 98,500,000 | 96,300,000 | · | 95,493,996 | 86,580,516 | 84,286,292 | · | 71,664,493 | 70,897,991 | 70,368,478 | · | 70,054,173 | |
| Shares (Diluted) | 101,900,000 | 100,600,000 | · | 99,771,297 | 98,500,000 | 96,300,000 | · | 95,493,996 | 86,580,516 | 84,286,292 | · | 71,664,493 | 70,897,991 | 70,368,478 | · | 70,054,173 | |
| EBITDA | $-75M | $-161M | · | $-171M | $-108M | $-134M | · | $-132M | $-116M | $-157M | · | $-145M | $-148M | $-149M | · | $-225M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $175M | $421M | $203M | $176M | $127M | $174M | $151M | $481M | $112M | $214M | $73M | $102M | $86M | $133M | $392M | |
| Receivables | $200M | $121M | $158M | $113M | $124M | $99M | $122M | $93M | $106M | $100M | · | $79M | $71M | $43M | · | $31M | |
| Inventory | $59M | $55M | $52M | $52M | $46M | $46M | $45M | $43M | $40M | $36M | · | $32M | $28M | $27M | · | $22M | |
| Prepaid Expense | $55M | $68M | $61M | $53M | $61M | $60M | $40M | · | · | · | · | $46M | $51M | $67M | · | $71M | |
| Other Current Assets | · | · | · | · | · | · | · | $41M | $55M | $48M | · | · | · | · | · | · | |
| Current Assets | $606M | $657M | $951M | $643M | $720M | $699M | $817M | $800M | $965M | $596M | · | $599M | $702M | $766M | · | $1.01B | |
| PP&E (Net) | $235M | $239M | $244M | $250M | $256M | $261M | $266M | $272M | $279M | $285M | · | $297M | $289M | $278M | · | $235M | |
| PP&E (Gross) | · | · | $380M | · | · | · | $378M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $136M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | $44M | $44M | $44M | · | $44M | |
| Intangibles | $172M | $174M | $176M | $173M | $175M | $177M | $178M | $165M | $166M | $165M | · | $157M | $158M | $159M | · | $158M | |
| Other Non-current Assets | $63M | $61M | $60M | $58M | $60M | $62M | $63M | $54M | $54M | $60M | · | $28M | $26M | $22M | · | $18M | |
| Total Assets | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Accounts Payable | $39M | $42M | $31M | $41M | $34M | $47M | $39M | $36M | $60M | $41M | · | $33M | $42M | $59M | · | $24M | |
| Accrued Liabilities | $221M | $194M | $265M | $221M | $181M | $173M | $241M | $185M | $154M | $149M | · | $179M | $168M | $144M | · | $189M | |
| Current Liabilities | $351M | $325M | $384M | $340M | $293M | $292M | $344M | $285M | $273M | $246M | · | $254M | $244M | $218M | · | $227M | |
| Capital Leases | · | · | $24M | $22M | $25M | $28M | $30M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | · | $32M | $32M | $32M | · | $33M | |
| Other Non-current Liabilities | $41M | $42M | $20M | $19M | $17M | $17M | $17M | $16M | $15M | $14M | · | $10M | $10M | $9M | · | $4M | |
| Total Liabilities | $1.55B | $1.52B | $1.60B | $1.17B | $1.15B | $1.16B | $1.24B | $1.18B | $1.19B | $1.17B | · | $1.21B | $1.18B | $1.16B | · | $1.15B | |
| Common Stock | $0 | $0 | $0 | $96.0K | $96.0K | $94.0K | $0 | $92.0K | $92.0K | $83.0K | · | $72.0K | $71.0K | $71.0K | · | $70.0K | |
| Paid-in Capital | $4.52B | $4.48B | $4.45B | $4.41B | $4.37B | $4.25B | $4.21B | $4.17B | $4.12B | $3.70B | · | $3.30B | $3.24B | $3.17B | · | $3.11B | |
| Retained Earnings | $-4.81B | $-4.72B | $-4.53B | $-4.40B | $-4.22B | $-4.11B | $-3.96B | $-3.82B | $-3.69B | $-3.56B | · | $-3.26B | $-3.10B | $-2.94B | · | $-2.63B | |
| Treasury Stock | $10M | $10M | $8M | $8M | $8M | $8M | $4M | $4M | $3M | $3M | · | $381.0K | $381.0K | $356.0K | · | · | |
| AOCI | $0 | $0 | $1M | $820.0K | $-268.0K | $-341.0K | $-1M | $896.0K | $-1M | $-431.0K | · | $-2M | $-3M | $-4M | · | $-10M | |
| Stockholders' Equity | $-291M | $-236M | $-80M | $9M | $151M | $144M | $255M | $347M | $432M | $140M | $275M | $32M | $129M | $220M | $352M | $469M | |
| Liabilities + Equity | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Shares Outstanding | 98,600,000 | 98,300,000 | 96,600,000 | 96,442,027 | 96,353,634 | 93,903,785 | 92,500,000 | 92,304,317 | 92,135,384 | 83,094,037 | 82,300,000 | 72,174,307 | 71,465,424 | 70,660,249 | 70,197,297 | 70,079,777 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $8M | $7M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-20M | · | · | · | $-24M | · | · | · | $-29M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-97M | $-197M | $-100M | $-91M | $-108M | $-166M | $-79M | $-67M | $-77M | $-191M | $-84M | $-118M | $-116M | $-157M | $-90M | $-95M | |
| CapEx | $1M | $1M | $938.0K | $1M | $2M | $1M | $163.0K | $2M | $2M | $3M | $1M | $4M | $14M | $25M | $27M | $26M | |
| Investing Cash Flow | $44M | $-49M | $-72M | $117M | $71M | $120M | $103M | $-276M | $61M | $94M | $-107M | $64M | $99M | $111M | $-172M | $-162M | |
| Financing Cash Flow | · | · | $394M | $2.0K | $84M | $157.0K | $3M | $11M | $385M | $-58.0K | $330M | $25M | $33M | $-722.0K | $2M | $492M | |
| Net Change in Cash | $-49M | $-247M | $221M | $26M | $49M | $-45M | $24M | $-330M | $368M | $-97M | $140M | $-29M | $16M | $-46M | $-259M | $234M | |
| Free Cash Flow | · | $-198M | · | · | · | $-168M | · | · | · | $-194M | · | · | · | $-182M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -35.0% | -124.3% | · | -106.8% | -64.8% | -102.6% | · | -94.6% | -79.1% | -151.9% | · | -148.0% | -136.6% | -153.3% | · | -248.1% | |
| Net Margin | -43.0% | -136.0% | · | -112.8% | -69.0% | -108.5% | · | -95.7% | -89.5% | -156.8% | · | -162.8% | -147.6% | -163.2% | · | -270.2% | |
| Pretax Margin | -42.5% | -135.3% | · | -112.3% | -68.5% | -107.5% | · | -95.5% | -88.9% | -156.4% | · | -162.2% | -146.9% | -162.7% | · | -263.3% | |
| EBITDA Margin | -35.0% | -118.4% | · | -106.8% | -64.8% | -96.2% | · | -94.6% | -79.1% | -143.8% | · | -148.0% | -136.6% | -148.1% | · | -248.1% | |
| ROA | -7.2% | -14.2% | · | -13.2% | -7.9% | -11.5% | · | -9.6% | -9.0% | -12.7% | · | -11.2% | -12.2% | -11.8% | · | -15.8% | |
| ROE | 131.7% | 403.2% | · | -101.4% | -39.4% | -106.2% | · | -70.5% | -46.9% | -94.6% | · | -63.8% | -39.6% | -32.2% | · | -34.9% | |
| ROIC | 26.1% | 72.0% | · | -1874.9% | -71.9% | -100.0% | · | -38.1% | -27.1% | -118.2% | · | -459.4% | -115.2% | -70.1% | · | -49.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.0 | · | 1.9 | 2.5 | 2.4 | · | 2.8 | 3.5 | 2.4 | · | 2.4 | 2.9 | 3.5 | · | 4.5 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.0 | 0.8 | · | 0.9 | 2.1 | 0.9 | · | 0.6 | 0.7 | 0.6 | · | 1.9 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.6 | 1.4 | 1.4 | · | 1.6 | 1.7 | 1.5 | · | 1.8 | 2.0 | 2.8 | · | 3.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.95 | $-2.40 | · | $0.10 | $1.57 | $1.54 | · | $3.76 | $4.69 | $1.69 | · | $0.44 | $1.81 | $3.12 | · | $6.69 | |
| Revenue / Share | $2.10 | $1.35 | · | $1.60 | $1.69 | $1.45 | · | $1.46 | $1.70 | $1.29 | · | $1.37 | $1.53 | $1.43 | · | $1.29 | |
| Cash Flow / Share | · | $-1.96 | · | · | · | $-1.73 | · | · | · | $-2.26 | · | · | · | $-2.23 | · | · | |
| Cash / Share | $1.27 | $1.78 | · | $2.10 | $1.83 | $1.35 | · | $1.63 | $5.22 | $1.35 | · | $1.01 | $1.43 | $1.21 | · | $5.59 | |
| EPS (TTM) | $-5.83 | $-6.10 | · | $-5.89 | $-5.48 | $-5.83 | · | $-6.39 | $-7.22 | $-7.95 | · | $-8.98 | $-10.25 | $-10.26 | · | $-9.74 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $717M | $670M | · | $631M | $610M | $590M | · | $522M | $481M | $442M | · | $410M | $403M | $384M | · | $343M | |
| Net Income TTM | $-586M | $-609M | · | $-580M | $-533M | $-549M | · | $-559M | $-585M | $-614M | · | $-635M | $-721M | $-719M | · | $-678M | |
| Market Cap | $3.29B | $2.06B | · | $2.90B | $3.50B | $3.40B | · | $5.13B | $3.79B | $3.88B | · | $2.57B | $3.30B | $2.83B | · | $2.90B | |
| P/E | -5.7 | -3.4 | · | -5.1 | -6.6 | -6.2 | · | -8.7 | -5.7 | -5.9 | · | -4.0 | -4.5 | -3.9 | · | -4.3 | |
| P/S | 4.6 | 3.1 | · | 4.6 | 5.7 | 5.8 | · | 9.8 | 7.9 | 8.8 | · | 6.3 | 8.2 | 7.4 | · | 8.5 | |
| P/B | -11.3 | -8.7 | · | 316.7 | 23.2 | 23.6 | · | 14.8 | 8.8 | 27.7 | · | 81.1 | 25.5 | 12.9 | · | 6.2 | |
| P / Tangible Book | · | · | · | · | · | · | · | 37.3 | 17.1 | · | · | · | · | 167.6 | · | 10.9 | |
| P / Cash Flow | · | -10.5 | · | · | · | -20.4 | · | · | · | -20.3 | · | · | · | -18.1 | · | · | |
| Earnings Yield | -17.5% | -29.1% | · | -19.6% | -15.1% | -16.1% | · | -11.5% | -17.6% | -17.0% | · | -25.2% | -22.2% | -25.6% | · | -23.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $673M | $560M | $434M | $363M | $351M |
| Margen Operativo % | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% |
| Beneficio neto | $-575M | $-569M | $-607M | $-707M | $-454M |
| EPS Diluido | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 |
| Ratio Rápido | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-472M | $-422M | $-519M | $-497M | $-412M |
Propietarios institucionales (13F) 346 declarantes · $3.8B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
346
Valor en tenencia
$3.8B
Nuevas posiciones
63
Posiciones cerradas
37
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 63 (-2 vs trimestre anterior) | 37 (-8 vs trimestre anterior) | 120 (-9 vs trimestre anterior) | 100 (+13 vs trimestre anterior) | +10.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $355 746 262 | 10 654 276 | 9,26% | Acciones |
| RTW INVESTMENTS, LP | $260 338 324 | 7 796 895 | 6,77% | Acciones |
| VANGUARD GROUP INC | $236 067 745 | 10 263 815 | 6,14% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $226 722 608 | 6 790 135 | 5,90% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $214 144 806 | 6 560 809 | 5,57% | Acciones |
| STATE STREET CORP | $205 641 197 | 6 158 766 | 5,35% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $143 459 834 | 4 296 491 | 3,73% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $120 911 868 | 3 621 200 | 3,15% | Acciones |
| SANDS CAPITAL MANAGEMENT, LLC | $105 457 908 | 3 158 368 | 2,74% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $98 157 217 | 2 939 719 | 2,55% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $95 092 590 | 2 847 936 | 2,47% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $86 123 888 | 2 578 828 | 2,24% | Acciones |
| Bellevue Group AG | $66 204 857 | 1 982 775 | 1,72% | Acciones |
| D. E. Shaw & Co., Inc. | $57 771 145 | 1 730 193 | 1,50% | Acciones |
| Sofinnova Investments, Inc. | $57 347 492 | 1 717 505 | 1,49% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52 756 200 | 1 580 000 | 1,37% | Acciones |
| MPM BIOIMPACT LLC | $47 354 199 | 1 418 215 | 1,23% | Acciones |
| MORGAN STANLEY | $44 235 265 | 1 324 805 | 1,15% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $41 752 993 | 1 250 464 | 1,09% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41 455 555 | 1 241 556 | 1,08% | Acciones |
| BANK OF AMERICA CORP /DE/ | $38 346 863 | 1 148 454 | 1,00% | Acciones |
| Candriam S.C.A. | $33 419 286 | 1 001 841 | 0,87% | Acciones |
| Rock Springs Capital Management LP | $32 316 678 | 967 855 | 0,84% | Acciones |
| Jefferies Financial Group Inc. | $31 040 212 | 929 626 | 0,81% | Acciones |
| NORTHERN TRUST CORP | $30 729 285 | 920 314 | 0,80% | Acciones |
| Eagle Health Investments LP | $29 520 800 | 884 121 | 0,77% | Acciones |
| Qube Research & Technologies Ltd | $29 457 292 | 882 219 | 0,77% | Acciones |
| Russell Investments Group, Ltd. | $26 181 069 | 784 099 | 0,68% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $25 403 947 | 760 825 | 0,66% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25 377 702 | 760 039 | 0,66% | Acciones |
| Caption Management, LLC | $24 000 732 | 718 800 | 0,62% | Opción de venta |
| Nuveen, LLC | $23 171 291 | 693 959 | 0,60% | Acciones |
| Pictet Asset Management Holding SA | $23 159 948 | 753 695 | 0,60% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $22 418 413 | 671 411 | 0,58% | Acciones |
| UBS Group AG | $21 960 569 | 657 699 | 0,57% | Acciones |
| GREAT POINT PARTNERS LLC | $20 034 000 | 600 000 | 0,52% | Opción de venta |
| Palo Alto Investors LP | $19 916 968 | 596 495 | 0,52% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $19 649 815 | 588 494 | 0,51% | Acciones |
| Legal & General Group Plc | $19 583 902 | 586 520 | 0,51% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $19 574 220 | 586 230 | 0,51% | Acciones |
| FMR LLC | $19 260 990 | 576 849 | 0,50% | Acciones |
| GOLDMAN SACHS GROUP INC | $19 210 535 | 575 338 | 0,50% | Acciones |
| Trexquant Investment LP | $18 577 695 | 556 385 | 0,48% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16 995 510 | 509 000 | 0,44% | Opción de venta |
| Sofinnova Investments, Inc. | $16 695 000 | 500 000 | 0,43% | Opción de compra |
| BNP PARIBAS FINANCIAL MARKETS | $16 633 796 | 498 167 | 0,43% | Acciones |
| Bank of New York Mellon Corp | $15 716 566 | 470 697 | 0,41% | Acciones |
| JPMORGAN CHASE & CO | $15 268 024 | 493 126 | 0,40% | Acciones |
| TORONTO DOMINION BANK | $13 856 850 | 415 000 | 0,36% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $13 813 443 | 413 700 | 0,36% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 6 de noviembre de 2020 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 15 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Emil D Kakkis | President & CEO | 16 de abril de 2026 A | 735 739 | 0 | 1 | $-1 240 411 |
| Howard Horn | Chief Financial Officer | 3 de agosto de 2026 S | 96 295 | 0 | 12 | $-1 332 021 |
| Mardi Dier | CFO & Executive Vice President | 14 de octubre de 2022 S | 66 695 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Chief Operating Officer | 4 de octubre de 2019 F | 18 703 | 0 | 0 | $0 |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | 15 de septiembre de 2026 S | 67 863 | 0 | 4 | $-59 794 |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 3 de agosto de 2026 S | 92 562 | 0 | 5 | $-487 890 |
| Eric Crombez | EVP and Chief Medical Officer | 5 de mayo de 2026 S | 111 189 | 0 | 2 | $-168 847 |
| Erik Harris | EVP & Chief Commercial Officer | 16 de abril de 2026 A | 118 410 | 0 | 1 | $-240 289 |
| John Richard Pinion | EVP, Chief Quality Operations Officer | 16 de abril de 2026 A | 133 142 | 0 | 1 | $-228 661 |
| Dennis Karl Huang | EVP, Chief Technical Operations Officer | 16 de abril de 2026 A | 147 845 | 0 | 0 | $0 |
| Thomas Richard Kassberg | CBO & EVP | 3 de marzo de 2025 F | 264 730 | 0 | 0 | $0 |
| Camille L Bedrosian | EVP and Chief Medical Officer | 1 de marzo de 2023 S | 46 720 | 0 | 0 | $0 |
| Shalini Sharp | EVP, Finance | 14 de octubre de 2020 S | 97 812 | 0 | 0 | $0 |
| Jayson Donald Alexander Dallas | EVP & Chief Commercial Officer | 1 de junio de 2018 F | 23 830 | 0 | 0 | $0 |
| Sunil Agarwal | Chief Medical Officer | 19 de agosto de 2016 F | 9 136 | 0 | 0 | $0 |
| Corazon (Corsee) D. Sanders | Consejero | 15 de junio de 2026 S | 21 095 | 0 | 1 | $-50 100 |
| Amrit Ray | Consejero | 14 de mayo de 2026 A | 31 116 | 0 | 0 | $0 |
| Shehnaaz Suliman | Consejero | 14 de mayo de 2026 A | 27 951 | 0 | 1 | $-144 189 |
| Deborah Dunsire | Consejero | 14 de mayo de 2026 A | 38 566 | 0 | 0 | $0 |
| Daniel G Welch | Consejero | 14 de mayo de 2026 A | 40 441 | 0 | 0 | $0 |
| Lars Ekman | Consejero | 24 de junio de 2022 A | 17 745 | 0 | 0 | $0 |
| William Aliski | Consejero | 24 de junio de 2021 A | 66 849 | 0 | 0 | $0 |
| Clay B Siegall | Consejero | 10 de agosto de 2020 M | 2 550 | 0 | 0 | $0 |
| Eran Nadav | Consejero | 10 de julio de 2014 A | · | 0 | 0 | $0 |
| Marten Steen | Consejero | 30 de enero de 2014 A | · | 0 | 0 | $0 |
| Matthew K Fust | · | 14 de mayo de 2026 A | 33 696 | 0 | 0 | $0 |
| Michael Narachi | · | 14 de mayo de 2026 A | 40 441 | 0 | 0 | $0 |
| FMR LLC | · | 1 de agosto de 2014 J | 1 457 994 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 37 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,41% | 55 734 NS | 31 de julio de 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,06% | 72 355 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,63% | 124 269 NS | 31 de julio de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,30% | 154 710 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,27% | 3 948 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,18% | 1 698 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 207 179 SH | 1 de octubre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 46 526 SH | 19 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,10% | 3 532 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 556 246 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 6 956 SH | 1 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,10% | 687 817 SH | 11 de septiembre de 2026 | Diario |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,10% | 52 252 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 26 477 NS | 31 de julio de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1 238 640 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 46 723 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,08% | 46 288 NS | 31 de julio de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 14 014 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,05% | 2 465 688 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,04% | 405 050 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1 127 405 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2 146 622 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,04% | 251 571 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,03% | 61 868 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 39 676 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 10 407 SH | 11 de septiembre de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 5 013 SH | 11 de septiembre de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,01% | 21 519 SH | 19 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 140 625 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 25 782 SH | 10 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 987 783 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 76 072 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8 035 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 493 596 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 4 391 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 14 131 SH | 11 de septiembre de 2026 | Diario |
RARE Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 26 analistas
COMPRA
Objetivo mediano
$28.00
+84,0%
9 34,6%
Compra fuerte
14 53,8%
Compra
3 11,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
19 analistas · 2026-10-03Objetivo medio $28.05 +84,3%
← Por Debajo de Todos los Objetivos
Precio Actual $15.22
Mín$18.00
Media$28.05
Máx$40.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| COAG | · | · | · | · | · | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 5, 2026